The
global Smoking
Cessation And Nicotine De-Addiction Market is
expected to reach over USD 21.8 billion by 2024 according to a new report by
Grand View Research, Inc.
The
base of population addicted to smoking is rapidly increasing across the globe.
This population subset majorly includes teenagers and the working population.
Smoking-related mortality is very high. The increasing desire to quit smoking
and the numerous health complications associated with smoking serve as strong
incentives for companies to introduce novel smoking cessation products, such as
Revolymer, which has introduced the next generation nicotine gums to help
smokers quit smoking. The launch of these improved and innovative nicotine
replacement therapy products is to serve as a high impact rendering driver for
the growth of the smoking cessation and nicotine de-addiction market.
The
growing incidence of target diseases such as chronic obstructive pulmonary
disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing
awareness pertaining to the hazardous side-effects of smoking are the factors
expected to promote market expansion. Educational institutions remain active in
organizing various campaigns and programs to spread information about the
harmful effects and consequences of smoking so as to increase young population
awareness.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market
http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market
Further key findings from the study suggest:
- Nicotine
Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine
addiction product market in 2015. Majorly used NRT products include
nicotine chewing gums and the transdermal patches. Increased availability
and the introduction of the ingestible nicotine products with different
flavors are the factors responsible for its large market share.
- The
e-cigarette segment is anticipated to grow at a CAGR of19.0% over the
forecast period. The major factors responsible for the growth of the
E-cigarette market include the introduction of second and third generation
e-cigarettes, the availability of various flavored products, the presence
of numerous vendors operating and selling e-cigarettes under different
brand names.
- North
America held a large market share of over 35.0% in 2015 owing to the high
awareness levels of nicotine de-addiction products with around 90% of the
U.S. population were identified as aware of e-cigarettes in 2015
- Asia Pacific
is the fastest growing market. The registration of nicotine de-addiction
products and e-cigarettes as well as the strengthening of the company
distribution channels in countries, such as China, India, and Australia
are expected to support the growth over the forecast period
- Some key
players of this market are Pfizer, Inc., Cipla Ltd., Novartis
International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd.,
McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC
- The market
players are making slow but steady progress in the e-cigarette market by
focusing on the development, commercialization, and distribution of the
FDA approved nicotine products. For instance, in 2014, Victory Electronic
Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand
their distribution channels and attain wider market coverage.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment